KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Accured Expenses (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Change in Accured Expenses for 8 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 72.68% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $665000.0 through Dec 2025, down 0.89% year-over-year, with the annual reading at $665000.0 for FY2025, 0.89% down from the prior year.
  • Change in Accured Expenses hit $1.2 million in Q4 2025 for Adaptive Biotechnologies, down from $5.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.5 million in Q4 2022 to a low of -$15.9 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $349000.0 across 5 years, with a median of $786000.0 in 2024.
  • Biggest five-year swings in Change in Accured Expenses: crashed 150.71% in 2023 and later surged 10093.22% in 2025.
  • Year by year, Change in Accured Expenses stood at -$1.6 million in 2021, then skyrocketed by 767.3% to $10.5 million in 2022, then tumbled by 49.3% to $5.3 million in 2023, then decreased by 20.13% to $4.3 million in 2024, then tumbled by 72.68% to $1.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ADPT at $1.2 million in Q4 2025, $5.9 million in Q3 2025, and $3.3 million in Q2 2025.